Please try another search
Shanghai Medicilon Inc is a China-based company mainly engaged in pre-clinical comprehensive research and development services of biomedicine. The Company is committed to providing a full range of new drug research and development (R&D) services for pharmaceutical enterprises and other new drug R&D institutions. The Company's main businesses include drug discovery and pharmaceutical research and preclinical research. The drug discovery and pharmaceutical research mainly include services such as compound synthesis and screening, active pharmaceutical ingredients (API) and preparation technology research. The preclinical research services mainly include pharmacodynamics research, pharmacokinetics research, toxicology research and other services. The Company provides services for domestic and foreign customers such as the United States, Europe, Japan and South Korea.
Name | Age | Since | Title |
---|---|---|---|
Jinzhang Chen | - | - | Chairman of the Board |
Chunlin Chen | - | 2004 | Co-Founder, CEO & Executive Director |
Changqing Lin | - | - | Director |
Wang Lei | 24 | - | Employee Representative Supervisor |
Dawei Ma | 59 | - | Independent Director |
Weidong Lai | 65 | - | Independent Director |
Jinye Xu | 55 | - | Independent Director |
Guoxing Chen | - | - | Board Director |
Weichun Jin | - | - | Supervisor |
Jinna Cai | 59 | 2021 | CBO, Deputy GM & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review